trial

The Effect of D-serine as add-on Therapy in Recent-onset Psychosis

NCTId NCT04140773
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 3 (actual)
Sponsored by Dragos Inta
Primary completion 2022-08-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
3 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2021-11-25
Primary completion
2022-08-31
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
D-serine

Sponsors

Dragos IntaLead Sponsor

Sites

1 total
Basel, Switzerland

Facts & assertions

4 sourced
Enrollment
3
Phase
NA
Primary Completion Date
2022-08-31
Status
TERMINATED
relationships
The graph out of here
drug
D-serine
drug
lead_sponsor
Dragos Inta
company
indication
Psychotic Disorder
indication
Psychotic Disorders
indication